Evidence map›Paper›PMID 25237067›Full record

ArticleCancer research2014

Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation.

Daniel C Berry, Liraz Levi, Noa Noy

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Targeting the JAK/STAT signalling axis in cancer: chemopreventive potential of natural compounds with emerging focus on retinoids.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Review
  18. Article
  19. Parsing β-catenin's cell adhesion and Wnt signaling functions in malignant mammary tumor progression.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel C BerryDepartment of Cellular & Molecular Medicine, Lerner Research Institute, Cleveland Clinic, and Departments of Pharmacology and Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Liraz LeviDepartment of Cellular & Molecular Medicine, Lerner Research Institute, Cleveland Clinic, and Departments of Pharmacology and Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Noa NoyDepartment of Cellular & Molecular Medicine, Lerner Research Institute, Cleveland Clinic, and Departments of Pharmacology and Nutrition, Case Western Reserve University School of Medicine, Cleveland, Ohio. noyn@ccf.org.
Cleveland Clinic Lerner College of Medicine · US

Funding

FUNCTIONS OF INTRACELLULAR LIPID-BINDING PROTEINSR01DK060684 · NIDDK · CORNELL UNIVERSITY ITHACA · PI BROWN, JONATHAN MARK · 2002 to 2015
$4.3M
Transcriptional signalling by vitamin AR01DK088969 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI NOY, NOA · 2010 to 2013
$1.3M
NIDDK NIH HHS R01 DK060684NIDDK NIH HHS R01-DK060684NIDDK NIH HHS R01-DK088669NIDDK NIH HHS R01 DK088969
6 · The paper itself

Abstract

Vitamin A, retinol, circulates in blood bound to retinol-binding protein (RBP). At some tissues, RBP is recognized by STRA6, a plasma membrane protein that serves a dual role: it transports retinol from extracellular RBP into cells and it transduces a signaling cascade mediated by the Janus kinase JAK2 and the transcription factors STAT3 and STAT5. We show here that expression of RBP and STRA6 is markedly upregulated in human breast and colon tumors, that holo-RBP/STRA6 signaling promotes oncogenic properties, and that STRA6 expression is critical for tumor formation by colon carcinoma cells in vivo. The holo-RBP/STRA6 pathway also efficiently induces fibroblasts to undergo oncogenic transformation, rendering them highly tumorigenic. These data establish that holo-RBP and its receptor STRA6 are potent oncogenes and suggest that the pathway is a novel target for therapy of some human cancers.

Indexed as

Cell Transformation, NeoplasticColonic NeoplasmsGene Expression Regulation, NeoplasticHCT116 CellsHep G2 CellsHumansJanus Kinase 2Membrane ProteinsRetinol-Binding ProteinsSignal TransductionVitamin AJAK2 protein, humanJanus Kinase 2Membrane ProteinsRetinol-Binding ProteinsSTRA6 protein, humanVitamin A

Identifiers

PMID25237067
PMCPMC4216741
OpenAlexW2035037439

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.